Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | NBTXR3 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
NBTXR3 is a nanoparticle formulation of hafnium oxide, which potentially enhances radiotherapy (PMID: 31296491). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C98280 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Ipilimumab + NBTXR3 + Nivolumab | Ipilimumab NBTXR3 Nivolumab | 0 | 1 |
| NBTXR3 | NBTXR3 | 0 | 4 |
| NBTXR3 + Pembrolizumab | NBTXR3 Pembrolizumab | 0 | 2 |
| NBTXR3 + Radiotherapy | NBTXR3 Radiotherapy | 0 | 0 |
| NBTXR3 + unspecified PD-1 antibody | NBTXR3 unspecified PD-1 antibody | 0 | 1 |